This inventor holds 3 USPTO granted patents. Top assignee: Vanderbilt University. Active years: 2002-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2002-2012
Title: The Innovative Contributions of Daniel Robinson
Introduction
Daniel Robinson is a notable inventor based in Lexington, KY (US). He has made significant contributions to the field of biotechnology, particularly in the delivery of biologically active molecules into cells. With a total of 3 patents, his work has the potential to impact various therapeutic applications.
Latest Patents
Robinson's latest patents include innovative methods for importing biologically active molecules into cells. One of his inventions focuses on compositions that facilitate the delivery of peptides, nucleic acids, and therapeutic agents by linking them to an importation competent signal peptide. This method can be utilized for peptide therapy, gene transfer, and antisense therapy, particularly in regulating systemic inflammatory response syndromes such as endotoxic shock. Another patent addresses the use of cell-permeable peptides to inhibit inflammatory reactions, which can be applied to treat and prevent various inflammatory conditions, including autoimmune diseases and localized inflammatory reactions.
Career Highlights
Robinson is affiliated with Vanderbilt University, where he continues to advance his research in biotechnology. His work is characterized by a commitment to developing innovative solutions for complex medical challenges.
Collaborations
Some of his notable coworkers include Ruth Ann Veach and Robert D Collins, who contribute to the collaborative environment that fosters innovation at Vanderbilt University.
Conclusion
Daniel Robinson's contributions to the field of biotechnology through his patents and research at Vanderbilt University highlight his role as a significant inventor. His work in the delivery of biologically active molecules has the potential to transform therapeutic approaches to inflammatory diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
